OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of B cells in the pathogenesis of systemic sclerosis: an update
Lazaros I. Sakkas, Christina G. Katsiari, Dimitrios Daoussis, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 5, pp. 1780-1786
Closed Access | Times Cited: 11

Showing 11 citing articles:

Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis
Jérôme Avouac, Anne Cauvet, Cindy Orvain, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 2, pp. 268-278
Closed Access | Times Cited: 11

New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases
B Chen, Yuhua Wang, Guangjie Chen
Nutrients (2023) Vol. 15, Iss. 21, pp. 4584-4584
Open Access | Times Cited: 10

Beyond circulating B cells: Characteristics and role of tissue-infiltrating B cells in systemic sclerosis
Mathilde Le Maître, Thomas Guerrier, S. Sangès, et al.
Autoimmunity Reviews (2025) Vol. 24, Iss. 5, pp. 103782-103782
Open Access

Mendelian Randomization Unveils a Causal Relationship Between Inflammation, Metabolism, and Systemic Sclerosis
Yuanyuan Zeng, Wen Zeng, Zhipeng Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

The ‘whole landscape’ of research on systemic sclerosis over the past 73 years
Meng‐Di Zhang, Wan‐Ying Huang, Jia‐Yuan Luo, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 5, pp. 103538-103538
Closed Access | Times Cited: 3

CD32 (FcγRIIB) expression is low on CD21low B cells from systemic sclerosis patients with digital ulcers, interstitial lung disease, and anti-topoisomerase I autoantibodies
E. Kourkouni, Sotirios G. Tsiogkas, Αthanasios Mavropoulos, et al.
Clinical Immunology (2024) Vol. 262, pp. 110195-110195
Closed Access | Times Cited: 2

Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review
Anna Bazsó, Péter Szodoray, Yehuda Shoenfeld, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 10, pp. 3055-3072
Open Access | Times Cited: 2

The B-cells paradigm in Systemic Sclerosis: an update on pathophysiology and B-cell targeted therapies
Cristina Scaletti, Sara Pratesi, Silvia Bellando-Randone, et al.
Clinical & Experimental Immunology (2024)
Open Access | Times Cited: 2

Systemic Sclerosis and Atherosclerosis: Potential Cellular Biomarkers and Mechanisms
Е. В. Герасимова, R. Shayakhmetova, Daria A. Gerasimova, et al.
Frontiers in Bioscience-Scholar (2023) Vol. 15, Iss. 4, pp. 16-16
Open Access | Times Cited: 6

Emotional intelligence: a novel predictor of quality of life in patients with systemic sclerosis
D. Karagianni, Theodora Simopoulou, Dimitrios P. Bogdanos, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1967-1974
Closed Access

More to B: the growing evidence to inform targeting B cells in scleroderma
Silvia Laura Bosello, Edward M Vital, Francesco Del Galdo
Lara D. Veeken (2022) Vol. 62, Iss. 5, pp. 1730-1732
Open Access

Page 1

Scroll to top